Opioid Use Disorder Clinical Trials

Find Opioid Use Disorder Clinical Trials Near You

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After Discharge From the Emergency Department

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Project Summary The goal of this pilot clinical trial is to assess contingency management (CM) for increasing attendance at outpatient clinics after Medication for Opioid Use Disorder (MOUD) prescription and clinic referral occurred in the hospital Emergency Department (ED). * The researchers will compare usual care (UC)+CM to UC alone to see if 1) CM works to promote MOUD clinic attendance after discharge from the ED and 2) demonstrate feasibility of providing CM in the ED and outpatient MOUD clinic settings. * Researchers will randomize 30 adults who started MOUD in the ED into two conditions. These conditions consist of (A) UC alone: A referral to an outpatient buprenorphine or methadone provider with reminders from STAR program staff or (B) UC+CM: UC plus financial incentives dependent on MOUD clinic attendance to receive an MOUD prescription. The primary outcome of interest is the number of participants who receive their first MOUD prescription from the outpatient clinic after discharge from the ED in UC+CM compared to the UC-only condition. A secondary outcome will be the proportion of participants who kept attending outpatient MOUD treatment by the end of the 30-day study period between UC+CM and UC conditions. An exploratory outcome will be biochemically-verified illicit opioid abstinence measured at day 30.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• STAR referral to outpatient clinic (Addiction Treatment Center and Chittenden Clinic) with prescription for buprenorphine or methadone.

• Age ≥18 years.

• Provide informed consent.

Locations
United States
Vermont
University of Vermont Medical Center
RECRUITING
Burlington
Contact Information
Primary
Eric A Thrailkill, Ph.D.
eric.thrailkill@uvm.edu
602-291-7311
Time Frame
Start Date: 2025-09-02
Estimated Completion Date: 2027-05
Participants
Target number of participants: 30
Treatments
Experimental: Contingency Management
Participants assigned to this arm will receive incentives when they complete their first outpatient MOUD clinic visit and when they complete subsequent visits to pick up their MOUD prescription for the 30-day study period.
Active_comparator: Usual Care
All participants will receive standard outpatient care at their clinic.
Related Therapeutic Areas
Sponsors
Leads: University of Vermont
Collaborators: National Institute of General Medical Sciences (NIGMS)

This content was sourced from clinicaltrials.gov